Fluid-assisted electrosurgical instrument with shapeable electrode

Information

  • Patent Grant
  • 7967816
  • Patent Number
    7,967,816
  • Date Filed
    Friday, January 25, 2002
    22 years ago
  • Date Issued
    Tuesday, June 28, 2011
    13 years ago
Abstract
An electrosurgical instrument including an elongated shaft and a non-conductive handle. The shaft defines a proximal section, a distal section, and an internal lumen extending from the proximal section. The distal section forms an electrically conductive tip and defines at least one passage for distributing fluid. Further, the shaft is adapted to be transitionable from a straight state to a first bent state. The shaft is capable of independently maintaining the distinct shapes associated with the straight state and the first bent state. The handle is rigidly coupled to the proximal section of the shaft. With this in mind, an exterior surface of the shaft distal the handle and proximal the distal section is electrically non-conductive. In one preferred embodiment, the shaft is comprised of an elongated electrode body surrounded by an electrical insulator.
Description
BACKGROUND OF THE INVENTION

The present invention relates to an electrosurgical instrument and related system for use in surgical ablation or electrocautery procedures. More particularly, it relates to a fluid-assisted electrocautery instrument designed to be indifferent to rotational orientation and including a bendable shaft capable of independently maintaining a desired shape.


A wide variety of surgical procedures involve ablation or cauterization of selected tissue. For example, hemorrhoid or varicose vein removal can be accomplished by ablating the tissue in question. Additionally, tissue ablation and/or cauterization is commonly employed for the surgical treatment of cardiac arrhythmia, and in particular atrial fibrillation. In general terms, cardiac arrhythmia relates to disturbances in the heart's electrical system that causes the heart to beat irregularly, too fast or too slow. Irregular heartbeats, or arrhythmia, are caused by physiological or pathological disturbances in the discharge of electrical impulses from the sinoatrial node, in the transmission of the signal through heart tissue, or spontaneous, unexpected electrical signals generated within the heart. One type of arrhythmia is tachycardia, which is an abnormal rapidity of heart action. There are several different forms of atrial tachycardia, including atrial fibrillation and atrial flutter. With atrial fibrillation, instead of a single beat, numerous electrical impulses are generated by depolarizing tissue at one or more locations in the atria (or possible other locations). These unexpected electrical impulses produce irregular, often rapid heartbeats in the atrial muscles and ventricles. As to the location of the depolarizing tissue, it is generally agreed that the undesired electrical impulses often originate in the left atrial region of the heart, and in particular in one (or more) of the pulmonary veins extending from the left atrium. With this in mind, and as an alternative to drug therapy, ablation of the abnormal tissue or accessory pathway responsible for the atrial fibrillation has proven highly viable.


Regardless of exact application, ablation or cauterization of tissue is typically achieved by applying a destructive energy source to the target tissue, including radiofrequency electrical energy, direct current electrical energy, and the like. The ablative energy source is provided by an electrode that is otherwise placed in contact with the target tissue. For some treatments, the electrode can be formed as a part of a catheter that is otherwise sub-cutaneously delivered to the target site. While relatively non-invasive, catheter-based treatments present certain obstacles to achieving precisely located, complete ablation lesion patterns due to the highly flexible nature of the catheter itself, the confines of the surgical site; etc.


A highly viable alternative device is the hand-held electrosurgical instrument. As used herein, the term “electrosurgical instrument” includes a hand-held instrument capable of ablating tissue or cauterizing tissue, but does not include a catheter-based device. The instrument is relatively short (as compared to a catheter-based device), and rigidly couples the electrode tip to the instrument's handle that is otherwise held and manipulated by the surgeon. The rigid construction of the electrosurgical instrument requires direct, open access to the targeted tissue. Thus, for treatment of atrial fibrillation via an electrosurgical instrument, it is desirable to gain access to the patient's heart through one or more openings in the patient's chest (such as a sternotomy, a thoracotomy, a small incision and/or a port). In addition, the patient's heart may be opened through one or more incisions, thereby allowing access to the endocardial surface of the heart.


Once the target site (e.g., right atrium, left atrium, epicardial surface, endocardial surface, etc.) is accessible, the surgeon positions the electrode tip of the electrosurgical instrument at the target site. The tip is then energized, ablating (or for some applications, cauterizing) the contacted tissue. A desired lesion pattern is then created (e.g., portions of a known “Maze” procedure) by moving the tip in a desired fashion along the target site. In this regard, the surgeon can easily control positioning and movement of the tip, as the electrosurgical instrument is rigidly constructed and relatively short (in contrast to a catheter-based ablation technique).


Electrosurgical instruments, especially those used for the treatment of atrial fibrillation, have evolved to include additional features that provide improved results for particular procedures. For example, U.S. Pat. No. 5,897,553, the teachings of which are incorporated herein by reference, describes a fluid-assisted electrosurgical instrument that delivers a conductive solution to the target site in conjunction with electrical energy, thereby creating a “virtual” electrode. The virtual electrode technique has proven highly effective in achieving desired ablation while minimizing collateral tissue damage. Other electrosurgical instrument advancements have likewise optimized system performance. However, a common characteristic associated with available electrosurgical instruments is a “designed-in” directional orientation. That is to say, electrosurgical devices, and especially those used for atrial fibrillation treatment procedures, are curved along a length thereof, as exemplified by the electrosurgical instrument of U.S. Pat. No. 5,897,553. In theory, this permanent curved feature facilitates the particular procedure (or lesion pattern) for which the electrosurgical instrument is intended. Unfortunately, however, the actual lesion pattern formation technique and/or bodily structure may vary from what is expected, so that the curve is less than optimal. Additionally, the pre-made curve may be well suited for one portion of a particular procedure (e.g., right atrium ablation pattern during the Maze procedure), but entirely inapplicable to another portion (e.g., left atrium ablation during the Maze procedure). As a result, the electrosurgical instrument design may actually impede convenient use by a surgeon.


Electrosurgical instruments continue to be highly useful for performing a variety of surgical procedures, including surgical treatment of atrial fibrillation. While certain advancements have improved overall performance, the accepted practice of imparting a permanent curve or other shape variation into the instrument itself may impede optimal usage during a particular procedure. Therefore, a need exists for an electrosurgical instrument that, as initially presented to a surgeon, is indifferent to rotational orientation, and further is capable of independently maintaining a number of different shapes as desired by the surgeon.


SUMMARY OF THE INVENTION

One aspect of the present invention relates to an electrosurgical instrument including an elongated shaft and a non-conductive handle. The shaft defines a proximal section, a distal section, and an internal lumen extending from the proximal section. The distal section forms an electrically conductive rounded tip and defines at least one passage fluidly connected to the lumen. This passage distributes fluid from the internal lumen outwardly from the shaft. Further, the shaft is adapted to be transitionable from a straight state to a bent state, preferably a number of different bent states. In this regard, the shaft is capable of independently maintaining the distinct shapes associated with the straight state and the bent state(s). The non-conductive handle is rigidly coupled to the proximal section of the shaft. With this in mind, an exterior surface of the shaft distal the handle and proximal the distal section is electrically non-conductive. In one preferred embodiment, the shaft is comprised of an elongated electrode body and an electrical insulator. The electrode body defines the distal section and is rigidly coupled to the handle. The electrical insulator surrounds at least a portion of the electrode body proximal the distal section such that the tip is exposed.


During use, and when first presented to a surgeon, the shaft is in the straight state such that the electrosurgical instrument is effectively indifferent to a rotational orientation when the handle is grasped by the surgeon. Subsequently, the surgeon can bend the shaft to a desired shape (i.e., the bent state) being most useful for the particular electrosurgical procedure. During the procedure, a conductive fluid is directed onto the target site from the internal lumen via the passage. The tip then energizes the dispensed fluid, causing tissue ablation or cauterization.


Yet another aspect of the present invention relates to an electrosurgical system including an electrosurgical instrument, a source of conductive fluid, and an energy source. The electrosurgical instrument includes an elongated shaft and a non-conductive handle. The shaft defines a proximal section, a distal section, and an internal lumen extending from the proximal section. The distal section forms an electrically conductive rounded tip and defines at least one passage fluidly connected to the lumen. Further, the shaft is adapted to be transitionable from, and independently maintain a shape in, a straight state and a bent state. The handle is rigidly coupled to the proximal section of the shaft. An exterior surface of the shaft distal the handle and proximal the distal section is electrically non-conductive. The source of conductive fluid is fluidly connected to the internal lumen. Finally, the energy source is electrically connected to the tip. During use, the electrosurgical instrument can be presented to the target site in either the straight state or the bent state. Regardless, the shaft independently maintains the shape associated with the selected state. Conductive fluid is delivered from the conductive fluid source to the internal lumen, and is then distributed to the target site via the passage. The energy source is activated, thereby energizing the electrode tip. This action, in turn, energizes the distributed conductive fluid, causing desired tissue ablation or cauterization. In one preferred embodiment, the electrosurgical instrument further includes an indifferent, or non-ablating, electrode (such as a grounding patch). The indifferent electrode is electrically connected to the energy source and it is placed separately from the target site. For example, the indifferent electrode may be placed on the back of the patient.


Yet another aspect of the present invention relates to a method of performing an electrosurgical procedure. The method includes providing an electrosurgical instrument including an elongated shaft and, a handle. In this regard, the shaft defines a proximal section, a distal section, and an internal lumen. The proximal section is rigidly coupled to the handle, whereas the distal section forms a round tip. Finally, the internal lumen extends from the proximal section and is in fluid communication with at least one passage formed in the distal section. An exterior surface of the shaft distal the handle and proximal the distal section is electrically non-conductive. The shaft is provided in an initial straight state that otherwise defines a linear axis. The shaft is then bent to a first bent state in which a portion of the shaft is deflected relative to the linear axis. In this regard, the shaft independently maintains a shape of the first bent state. The tip is then positioned at a tissue target site. In one preferred embodiment, an indifferent electrode is placed in contact with the patient. Conductive fluid is dispensed from the passage to the tissue target site via the internal lumen. Finally, energy is applied to the dispensed fluid by energizing the tip. Subsequently, the energized tip and conductive fluid ablates or cauterizes tissue at the tissue target site. In one embodiment, the tissue target site comprises tissue of a patient's heart, and the method further includes accessing the tissue target site through one or more openings in the patient's chest. In another embodiment, after a first lesion pattern is formed at a first tissue target site, the shaft is bent to a second shape and the procedure repeated to effectuate a second lesion pattern at a second tissue target site.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a side view of an electrosurgical system in accordance with the present invention, including portions shown in block form;



FIG. 2 is a perspective view of an electrosurgical instrument portion of the system of FIG. 1, with a handle removed;



FIG. 3 is an enlarged, cross-sectional view of a portion of an electrosurgical instrument of FIG. 1 taken along the line 3-3;



FIG. 4A is an enlarged, perspective view of a distal portion of the electrosurgical instrument of FIG. 1;



FIG. 4B is an enlarged, perspective view of a distal portion of an alternative embodiment electrosurgical instrument in accordance with the present invention;



FIGS. 5A-5C are side views of the electrosurgical instrument of FIG. 1, illustrating exemplary shapes available during use of the electrosurgical instrument;



FIG. 6 is an enlarged, side view of a portion of an alternative embodiment electrosurgical instrument in accordance with the present invention;



FIG. 7A is cut-away illustration of a patient's heart depicting use of an electrosurgical instrument in accordance with the present invention during a surgical ablation procedure;



FIG. 7B is an enlarged illustration of a portion of FIG. 7A;



FIGS. 8A and 8B are side perspective views of an alternative electrosurgical instrument in accordance with the present invention;



FIG. 9A is an enlarged, perspective view of a distal portion of an alternative embodiment electrosurgical instrument in accordance with the present invention;



FIG. 9B is an enlarged, transverse, cross-sectional view of the electrosurgical instrument of FIG. 9A;



FIG. 9C is an enlarged, longitudinal, cross-sectional view of the electrosurgical instrument of FIG. 9A;



FIG. 10A is an enlarged, perspective view of a distal portion of an alternative embodiment electrosurgical instrument in accordance with the present invention;



FIG. 10B is an enlarged, cross-sectional view of the electrosurgical instrument of FIG. 10A;



FIG. 10C is an enlarged, perspective view of a distal portion of an alternative embodiment electrosurgical instrument in accordance with the present invention;



FIG. 10D is an enlarged, cross-sectional view of a portion of the electrosurgical instrument of FIG. 10C; and



FIG. 11 is an enlarged, cross-sectional view of a portion of an alternative embodiment electrosurgical instrument in accordance with the present invention.



FIG. 12 is a schematic illustration of a medical device 300 and an indicator light 302 on the medical device.





DESCRIPTION OF THE PREFERRED EMBODIMENTS

One preferred embodiment of an electrosurgical system 10 in accordance with the present invention is shown in FIG. 1. The system 10 is comprised of an electrosurgical instrument 12, a fluid source 14, a power source 16, and an indifferent electrode 18. The various components are described in greater detail below. In general terms, however, the fluid source 14 is fluidly connected to the electrosurgical instrument 12. Similarly, the power source 16 is electrically connected to the electrosurgical instrument 12 and to the indifferent electrode 18. During use, conductive fluid is delivered from the fluid source 14 to a distal portion of the electrosurgical instrument 12. The distributed fluid is energized by the electrosurgical instrument 12 via the power source 16. The so-energized conductive fluid is capable of forming a virtual electrode, which is capable of ablating or cauterizing contacted tissue.


The electrosurgical instrument 12 includes a handle 20 and a shaft 22. As described in greater detail below, the shaft 22 is rigidly coupled to the handle 20, and is transitionable from a straight state (as illustrated in FIG. 1) to a bent state (for example as shown in FIGS. 5B and 5C). In this regard, the shaft 22 independently maintains the shape associated with the particular state (i.e., straight or bent).


The handle 20 is preferably made of a sterilizable, rigid, and non-conductive material, such as a polymer or ceramic. Suitable polymers include rigid plastics, rubbers, acrylics, nylons, polystyrenes, polyvinylchlorides, polycarbonates, polyurethanes, polyethylenes, polypropylenes, polyamides, polyethers, polyesters, polyolefins, polyacrylates, polyisoprenes, fluoropolymers, combinations thereof or the like. Further, the handle 20 is ergonomically designed to comfortably rest within a surgeon's hand (not shown). To this end, the handle 20 may include a grip portion 24 that is circular in cross section. This configuration facilitates grasping of the handle 20, and thus of the electrosurgical instrument 12, at any position along the grip portion 24 regardless of an overall rotational orientation of the electrosurgical instrument 12. That is to say, due to the circular, cross-sectional shape of the grip portion 24, the electrosurgical instrument 12 can be rotated to any position relative to a central axis A, and still be conveniently grasped by the surgeon. In an even more preferred embodiment, the grip portion 24 defines a gradual, distally increasing diameter that provides an orientation feature to help a surgeon identify where along the length of the electrosurgical instrument 12 he or she is grasping. For example, if the surgeon grasps the electrosurgical instrument 12 out of his visual sight during a medical procedure, the surgeon may identify based on the grip portion's 24 diameter where along the instrument he has grasped. Finally, the grip portion 24 is preferably formed of a low durometer polymer. Suitable polymers include low durometer plastics, rubbers, silicones, acrylics, nylons, polystyrenes, polyvinylchlorides, polycarbonates, polyurethanes, polyethylenes, polypropylenes, polyamides, polyethers, polyesters, polyolefins, polyacrylates, polyisoprenes, fluoropolymers, combinations thereof or the like. The grip portion 24 alternatively may be a sponge-like or foam-like material, such as an open-cell material or a closed-cell material.


Regardless of exact configuration, the handle 20 forms or encompasses one or more central lumens (not shown). The lumen(s) provides a pathway for a line or tubing 26 from the fluid source 14 to the shaft 22, as well as a pathway for a line or wiring 28 from the power source 16 to the shaft 22. In this regard, FIG. 2 illustrates the electrosurgical instrument 12 with the handle 20 removed. The tubing 26 from the fluid source 14 (FIG. 1) is shown as extending to, and being fluidly connected with, the shaft 22. Similarly, the line 28 from the power source 16 (FIG. 1) is shown as extending to, and being electrically connected with, the shaft 22.


Returning to FIG. 1, the shaft 22 is an elongated, relatively rigid component defining a proximal section 40 and a distal section 42. The distal section 42 terminates in an electrically conductive tip 44. As described in greater detail below, the tip 44 is rounded, defining a uniform radius of curvature. With this configuration, the tip 44 is, similar to the handle 20, indifferent to rotational orientation of the electrosurgical device 12. That is to say, regardless of how a surgeon (not shown) grasps the handle 20 (i.e., the rotational position of the handle 20 relative to the central axis A), a profile of the tip 44 in all directions (e.g., in front of the surgeon's thumb position, behind the surgeon's thumb position, etc.) is always the same so that the tip 44 is readily maneuvered along tissue (not shown) in any direction. To this end, the rounded shape facilitates sliding movement of the tip 44 along the tissue.


With additional reference to FIG. 3, the shaft 22 defines an internal lumen 50 that is fluidly connected to the tubing 26. In this way, the internal lumen 50 delivers fluid from the fluid source 14 to the distal section 42.


With additional reference to FIG. 4A, the distal section 42 preferably forms a plurality of passages 52 that are fluidly connected to the internal lumen 50. The passages 52 are formed at or proximal the tip 44 and preferably are uniformly located relative to a circumference of the distal section 42. For example, in one preferred embodiment, two sets 54a, 54b of the passages 52 are provided, in addition to a central passage 54c at the tip 44. The passages 52 associated with each of the two sets 54a, 54b are circumferentially aligned, and uniformly spaced approximately 90° from one another. For example, in one embodiment, the passages 52 are uniformly located on a hemispherical portion of the tip 44 as described below. Alternatively, other numbers and locations are acceptable. By preferably uniformly spacing the passages 52, however, the distal section 42 is further formed to be indifferent to rotational orientation of the electrosurgical instrument 12. In other words, regardless of the rotational position of the electrosurgical instrument 12 and/or the direction of tip 44 movement, the passages 52 provide a relatively uniform disbursement of conductive fluid about the tip 44 via the internal lumen 50. In an alternative embodiment, the tip 44 is made of a porous material, that allows fluid to pass from the internal lumen 50 through the tip 44.


In another alternative embodiment, and as best shown in FIG. 4B, at least some of the passages 52 (for example, the passage set 54b) are located along a generally hemispherical portion 56 of the tip 44. This one preferred design facilitates a more complete delivery of liquid to a target site (not shown) that is otherwise contacted by the tip 44. In general terms, during an electrosurgical procedure, it is important that a sufficient volume of irrigation fluid is continually provided to the electrode tip 44/target site tissue interface to reduce the opportunity for tissue charring or desiccation. Previous electrosurgical designs positioned all of the passages 52 (except for the central passage 54c) along a cylindrical portion 58 of the tip 44 (as opposed to the generally hemispherical portion 56). With this prior design, where a particular surgical procedure required that the tip 44 be oriented such that the passages 52 are “below” the electrode tip 44/target site tissue interface, some or all of the irrigation liquid otherwise dispensed from the passages 52 (other than the central passage 54c) might flow away from the electrode tip 44 (or back along the shaft 22). The one preferred passage configuration of FIG. 4B overcomes this concern, as all of the irrigation liquid distributed from the passages 54b on the generally hemispherical portion 56 will be delivered to the electrode tip 44/target site tissue interface due to surface tension at the interface.


Regardless of passage location, a further preferred feature of the shaft 22 is a malleable or shapeable characteristic. In particular, and with additional reference to FIGS. 5A-5C, the shaft 22 is configured to be transitionable from an initial straight state (FIG. 5A) to a bent or curved state (FIGS. 5B and 5C). In this regard, the electrosurgical instrument 12, and in particular the shaft 22, is initially presented to a surgeon (not shown) in the straight state of FIG. 5A, whereby the shaft 22 assumes a straight shape defining the central axis A. In the straight state, the shaft 22 is indifferent to rotational orientation, such that the electrosurgical instrument 12 can be grasped at any rotational position and the tip 44 will be located at an identical position. Further, as previously described, a profile of the tip 44 is also uniform or identical at any rotational position of the electrosurgical instrument 12. Subsequently, depending upon the constraints of a particular electrosurgical procedure, the shaft 22 can be bent relative to the central axis A. Two examples of an applicable bent state or shape are provided in FIGS. 5B and 5C. In a preferred embodiment, the shaft 22 can be bent at any point along a length thereof, and can be formed to include multiple bends or curves. Regardless, the shaft 22 is configured to independently maintain the shape associated with the selected bent shape. That is to say, the shaft 22 does not require additional components (e.g., pull wires, etc.) to maintain the selected bent shape. Further, the shaft 22 is constructed such that a user can readily re-shape the shaft 22 back to the straight state of FIG. 5A and/or other desired bent configurations. Notably, the shaft 22 is configured to relatively rigidly maintain the selected shape such that when a sliding force is imparted onto the shaft 22 as the tip 44 dragged across tissue, the shaft 22 will not overtly deflect from the selected shape.


In one preferred embodiment, the above-described characteristics of the shaft 22 are achieved by forming the shaft 22 to include an elongated electrode body 60 and an electrical insulator covering 62 as shown in FIGS. 1 and 3. The electrode body 60 defines the proximal section 40 and the distal section 42 of the shaft 22. To this end, the proximal section 40 of the electrode body 60 is rigidly coupled to the handle 20. The insulator 62 covers a substantial portion of the electrode body 60, preferably leaving the distal section 42 exposed. In particular, the insulator 62 is positioned to encompass an entirety of the electrode body 60 distal the handle 20 and proximal the distal section 42 (and in particular, proximal the passages 52 and the tip 44).


In one preferred embodiment, the electrode body 60 is a tube formed of an electrically conductive, malleable material, preferably stainless steel, however other materials such as, for example, nitinol can be used. The passages 52 are preferably drilled, machined, laser cut, or otherwise formed through at least a portion of the electrode body 60. The passages or openings 52 may comprise circular holes, semi-circular holes, oval holes, rectangular slots, and/or other configurations for allowing fluid to pass.


The insulator 62 is formed of one or more electrically non-conductive materials, and serves to electrically insulate the encompassed portion of the electrode body 60. Multiple layers of electrically non-conductive materials can help prevent the likelihood of forming an electrical short along the length of the electrode body 60 due to a mechanical failure of one of the non-conductive materials. In this regard, the insulator 62 is preferably comprised of two materials having considerably different mechanical properties, e.g., a silicone and a fluoropolymer. In one preferred embodiment, a silicone tubing material is overlaid with a heat shrink fluoropolymer tubing material. Alternatively, the insulator 62 may be one or more non-conductive coatings applied over a portion of the electrode body 60. In addition to being non-conductive, the insulator 62 is preferably flexible and conforms to the electrode body 60 such that the insulator 62 does not impede desired shaping and re-shaping of the electrode body 60 as previously described.


It will be understood that the preferred construction of the shaft 22 to include the elongated electrode body 60 and the insulator 62 is but one available configuration. Alternatively, the shaft 22 can be constructed of an electrode material forming the tip 44, and a rigid or malleable, non-conductive tube rigidly connecting the tip 44 to the handle 20. The non-conductive tube can include one or more metal conductors, such as straight wire and/or windings for electrically connecting the tip 44 to the power source 16. Along these same lines, another alternative embodiment includes forming the tip 44 from an inherently porous material. For example, the tip 44 may comprise one or more porous polymers, metals, or ceramics. Further, the tip 44 may be coated with non-stick coatings such as PTFE or other types of coatings such as biological coatings. Another alternative embodiment includes construction of the shaft 22 to include one or more metal conductors, such as straight wire and/or windings inside a rigid or malleable non-conductive polymer tube. The non-conductive polymer tube includes one or more openings, such as holes, slots or pores (preferably corresponding with the passages 52 previously described), which allow conductive fluid to exit the polymer tube. The conductive fluid creates a virtual electrode via electrically connecting the one or more metal conductors to the target tissue. Conversely, the shaft 22 may comprise a polymer tube having one or more openings, such as holes, slots or pores (preferably corresponding with the passages 52 previously described), placed inside an electrical conductor, such as a metal tube having one or more openings, such as holes, slots or pores, or a metal winding having a spacing that allows conductive fluid to pass through, to control conductive fluid delivery through the electrical conductor. Finally, the insulator 62 may cover a portion of the metal tube or windings.


With respect to the above-described alternative embodiments, connection between the elongated tube and the separate tip 44 can be accomplished in a variety of manners. Once again, the elongated tube can comprise a conductive or non-conductive material(s), such as metal(s) or plastic(s). The elongated tube can be connected to the tip 44 via a variety of coupling techniques, including, for example, welding, laser welding, spin welding, crimping, gluing, soldering and press fitting. Alternatively, the distal end of the elongated tube and the tip 44 can be configured to threadably engage one another and/or mechanical engagement member(s) (e.g., pins, screws, rivets, etc.) can be employed. In another embodiment, the elongated tube is rigidly coupled to the tip 44. In yet another embodiment, the tip 44 can be moveably coupled to the elongated tube, whereby the tip 44 can be moved and/or locked relative to the elongated tube. For example, the tip 44 can be coupled to the elongated tube via one or more joints or hinges. The joints or hinges can be ball joints and/or joints that include a pin. To this end, a pin-type joint can be configured to allow the tip 44 to swivel relative to the elongated tube. Further, the joint(s) can be configured to move and lock into position. In addition, one or more actuators (e.g., knobs, buttons, levers, slides, etc.) can be located on, for example, the handle 20 (FIG. 1) for actuating the joint(s). With the above in mind, FIG. 6 illustrates a portion of an alternative embodiment shaft 22′ including a tip 44′ moveably coupled to an elongated tube 63 by a pin 64.


Returning to FIG. 1, the electrosurgical instrument 12 preferably includes a coupling member 65 for rigidly coupling the shaft 22 to the handle 20. The coupling member 65 can comprise one or more polymers, plastics, and/or rubbers. For example, the coupling member 65 can comprise one or more silicones, acrylics, nylons, polystyrenes, polyvinylchlorides, polycarbonates, polyurethanes, polyethylenes, polypropylenes, polyamides, polyethers, polyesters, polyolefins, polyacrylates, polyisoprenes, fluoropolymers, combinations thereof or the like. The coupling member 65 preferably forms a drip edge 66 to interrupt, divert and prevent any flow of liquid from the tip 44, down the shaft 22 and onto the handle 20, thereby preventing any electrically conducting fluid from contacting the surgeon.


Regardless of exact construction of the electrosurgical instrument 12, the fluid source 14 maintains a supply of conductive fluid (not shown), such as an energy-conducting fluid, an ionic fluid, a saline solution, a saturated saline solution, a Ringer's solution, etc. It is preferred that the conductive fluid be sterile. The conductive fluid can further comprise one or more contrast agents, and/or biological agents such as diagnostic agents, therapeutic agents or drugs. The biological agents may be found in nature (naturally occurring) or may be chemically synthesized.


As a point of reference, during use the conductive fluid serves to electrically couples the electrode tip 44 of electrosurgical instrument 12 to the tissue to be treated, thereby lowering the impedance at the target site. The conductive fluid may create a larger effective electrode surface. The conductive fluid can help cool the tip 44 of the electrosurgical instrument 12. The conductive fluid may keep the surface temperature of the tip 44 below the threshold for blood coagulation, which may clog the electrosurgical instrument 12. The conductive fluid may also cool the surface of the tissue thereby preventing over heating of the tissue which can cause popping, desiccation, burning and/or charring of the tissue. The burning and/or charring of the tissue may also clog the electrosurgical instrument 12. Therefore, use of the conductive fluid may reduce the need to remove a clogged electrosurgical instrument for cleaning or replacement. Further, charred tissue has high impedance, thereby making the transfer of RF energy difficult, and may limit the ability of the electrosurgical instrument 12 to form a transmural lesion. The delivery of conductive fluid during the electrosurgical process may help create deeper lesions that are more likely to be transmural. Transmurality is achieved when the full thickness of the target tissue is ablated. Continuous conductive fluid flow may ensure that a conductive fluid layer between the tip 44 and the contours of the tissue to be treated is created.


In one preferred embodiment, the fluid source 14 includes a fluid reservoir, such as a bag, a bottle or a canister, for maintaining a supply of conductive fluid previously described. With this configuration, the fluid reservoir can be positioned at an elevated location, thereby gravity feeding the conductive fluid to the electrosurgical instrument 12, or the fluid reservoir may be pressurized, thereby pressure feeding the conductive fluid to the electrosurgical instrument 12. For example, a pressure cuff may be placed around a flexible bag, such as an IV bag, of conductive fluid, thereby pressure feeding the conductive fluid to the electrosurgical instrument 12. Alternatively, the fluid source 14 can include, and/or be connected to, a manual or electrical pump (not shown), such as an infusion pump, a syringe pump, or a roller pump. The fluid source 14 can further comprise one or more orifices or fluid regulators, (e.g., valves, fluid reservoirs, conduits, lines, tubes and/or hoses) to control flow rates. The conduits, lines, tubes, or hoses may be flexible or rigid. For example, a flexible hose may be used to communicate fluid from the fluid source 14 to the electrosurgical instrument 12, thereby allowing electrosurgical instrument 12 to be easily manipulated by a surgeon. Alternatively, the fluid source 14 can be directly connected to, or incorporated into, the handle 20. For example, a pressurized canister of conductive fluid may be directly connected to the handle 20. Further, the fluid source 14 can comprise a syringe, a squeeze bulb and/or some other fluid moving means, device or system.


In another embodiment, the fluid source 14 further includes a surgeon-controlled switch (not shown). For example, a switch may be incorporated in or on the fluid source 14 or any other location easily and quickly accessed by a surgeon for regulation of conductive fluid delivery. The switch may be, for example, a hand switch, a foot switch, or a voice-activated switch comprising voice-recognition technologies.


In yet another alternative embodiment, the fluid source 14 includes a visual and/or audible signaling device (not shown) used to alert a surgeon to any change in the delivery of conductive fluid. For example, a beeping tone or flashing light can be used to alert the surgeon that a change has occurred in the delivery of conductive fluid.


The power source 16 is of a type known in the art, and is preferably a radio-frequency (RF) generator. The generator can be powered by AC current, DC current or it can be battery powered either by a disposable or re-chargeable battery. The generator can incorporate a controller (not shown) or any suitable processor to control power levels delivered to the electrosurgical instrument 12 based on information supplied to the generator/controller.


The above-described electrosurgical system 10, including the electrosurgical instrument 12, is useful for a number of different tissue ablation and cauterization procedures. For example, the electrosurgical system 10 can be used to remove hemorrhoids or varicose veins or stop esophageal bleeding to name but a few possible uses. Additionally, the electrosurgical system 10 is highly useful for the surgical treatment of cardiac arrhythmia, and in particular treatment of atrial fibrillation via ablation of atrial tissue. To this end, the Maze procedure, such as described in Cardiovascular Device Update, Vol. 1, No. 4, July 1995, pp. 2-3, the teachings of which are incorporated herein by reference, is a well known technique, whereby lesion patterns are created along specified areas of the atria. The Maze III procedure, a modified version of the original Maze procedure, has been described in Cardiac Surgery Operative Technique, Mosby Inc., 1997, pp. 410-419, the teachings of which are incorporated herein by reference. In an effort to reduce the complexity of the surgical Maze procedure, a modified Maze procedure was developed as described in The Surgical Treatment of Atrial Fibrillation, Medtronic Inc., 2001, the teachings of which are incorporated herein by reference.



FIG. 7A depicts use of the electrosurgical system 10, and in particular the electrosurgical instrument 12, performing a portion of the Maze procedure. In particular, FIG. 7A includes a representation of a heart 70 with its left atrium 72 exposed. Prior to use, the electrosurgical instrument 12 is provided to the surgeon (not shown) with the shaft 22 in the initial straight state (FIG. 1). The surgeon then evaluates the constraints presented by the tissue target site 74 and the desired lesion pattern to be formed. Following this evaluation, the surgeon determines an optimal shape of the shaft 22 most conducive to achieving the desired ablation/lesion pattern. With this evaluation in mind, the surgeon then transitions or bends the shaft 22 from the initial straight state to the bent state illustrated in FIG. 7A. Once again, the shaft 22 is configured to independently maintain this selected shape. The shaft 22 can be bent by hand and/or by use of bending jigs or tools.


Once the desired shape of the shaft 22 has been achieved, the tip 44 is directed to the tissue target site 74. An indifferent electrode (18 in FIG. 1, but not shown in FIG. 7A) is placed in contact with the patient. Conductive fluid from the fluid source 14 (FIG. 1) is delivered to the tissue target site 74 via the internal lumen 50 (FIG. 3), the passages 52 and/or the porous tip 44. Once sufficient fluid flow has been established, the tip 44 is energized via the power source 16 (FIG. 1). The tip 44, in turn, energizes the distributed fluid, thereby creating a virtual electrode that ablates contacted tissue. The surgeon then slides or drags the tip 44 along the left atrium 70 tissue, thereby creating a desired lesion pattern 78, as best shown in FIG. 7B. In this regard, the rigid coupling between the shaft 22 and the handle 20 allows the tip 44 to easily be slid along the atrial tissue via movement of the handle 20. Once the desired lesion pattern 78 has been completed, energization of the tip 44 is discontinued, as well as delivery of conductive fluid from the fluid source 14. If additional lesion patterns are required, the surgeon again evaluates the target tissue site, and re-forms the shaft 22 accordingly.


Notably, the shaft 22 need not necessarily be bent to perform a tissue ablation procedure. Instead, the tip 44 can be drug across the target site tissue 74 with the shaft 22 in the initial straight state. In this regard, because the shaft 22 is straight and the handle 20 (FIG. 1) is preferably circumferentially uniform, the electrosurgical instrument 12 does not have a discernable drag direction (as compared to the shaft 22 being bent or curved, whereby the curve inherently defines a most appropriate drag direction).


In addition to the one exemplary procedure described above, the electrosurgical instrument 12 may be positioned and used, for example, through a thoracotomy, through a sternotomy, percutaneously, transveneously, arthroscopically, endoscopically, for example, through a percutaneous port, through a stab wound or puncture, through a small incision, for example, in the chest, in the groin, in the abdomen, in the neck or in the knee, or in combinations thereof. It is also contemplated that the electrosurgical instrument 12 may be used in other ways, for example, in open-chest surgery on a heart in which the sternum is split and the rib cage opened with a retractor.


The electrosurgical system 10, and in particular the electrosurgical instrument 12, described above with respect to FIG. 1 is but one acceptable configuration in accordance with the present invention. That is to say, the system 10 and/or the instrument 12 can assume other forms and/or include additional features while still providing an electrosurgical instrument having a shaft that independently maintains varying shapes associated with a straight state and a bent state, and is indifferent to rotational orientation in the straight state.


For example, the electrosurgical instrument 12 can include a surgeon-controlled switch. For example, a switch may be incorporated in or on the electrosurgical instrument 12 or any other location easily and quickly accessed by the surgeon for regulation of the electrosurgical instrument 12 by the surgeon. The switch may be, for example, a hand switch, a foot switch, or a voice-activated switch comprising voice-recognition technologies. One or more switches may be incorporated into the grip portion 24 of the electrosurgical instrument 12. For example, a switch may be used to control conductive fluid delivery and/or power delivery. A switch incorporated into the grip portion 24 may be a switch, such as a membrane switch, encompassing the entire circumference of the electrosurgical instrument 12, thereby effectively being indifferent to a rotational orientation when the surgeon grasps the handle. That is to say, due to the cross-sectional shape of the switch, the electrosurgical instrument 12 may be rotated to any position relative to a central axis A, and still be conveniently controlled by the surgeon.


Alternatively, a hand switch connected to the electrosurgical instrument 12, but not incorporated into the electrosurgical instrument 12, may be used. For example, a switch designed to be worn by a surgeon, for example on a surgeon's thumb, may be used to activate and/or deactivate the electrosurgical instrument 12. A switch may be incorporated into a cuff or strap that is placed on or around the thumb or finger of a surgeon. Alternatively, a switch may be designed to fit comfortably in a surgeon's palm.


One or more visual and/or audible signals used to alert a surgeon to the completion or resumption of ablation, conductive fluid delivery and/or power delivery, for example, may be incorporated into the electrosurgical instrument 12. For example, a beeping tone or flashing light that increases in frequency as the ablation period ends or begins may be used. Alternatively or in addition, an indicator light otherwise located on the electrosurgical instrument can be inductively coupled to the power source 16 and adapted such that when power is being delivered to the electrosurgical instrument 12, the light is visible to the surgeon or other users.


An alternative embodiment electrosurgical instrument 112 is provided in FIGS. 8A and 8D. The electrosurgical instrument 112 is highly similar to the electrosurgical instrument 12 (FIG. 1) previously described, and includes a handle 120, a shaft 122, a fluid supply tube 126 and wiring 128. The shaft 122 is virtually identical to the shaft 22 (FIG. 1) previously described, and forms a tip 124 having passages (not shown) fluidly connected to an internal lumen (not shown). Further, the shaft 122 is adapted to be bendable from a straight state (FIG. 8A) to multiple bent states (one of which is illustrated in FIG. 8B), with the shaft 122 independently maintaining a shape associated with the particular state. Similar to previous embodiments, the fluid supply tube 126 fluidly connects the fluid source 14 (FIG. 1) to the shaft 122, whereas the wiring 128 electrically connects the power source 16 (FIG. 1) to the shaft 122.


The handle 120 varies from the handle 20 (FIG. 1) previously described in that the handle 120 does not define a curved outer surface. Instead, the handle 120 is hexagonal in transverse cross-section. This alternative configuration is, however, indifferent to rotational orientation when grasped by a user, thereby promoting the preferred ease of use feature previously described. Notably, the handle 120 can alternatively be formed to a variety of other symmetrical transverse cross-sectional shapes (e.g., octagonal, etc.).


In yet another alternative embodiment, the electrosurgical system 10 (FIG. 1) further includes a controller (not shown) that can also gather and process information from the electrosurgical instrument 12, 120, fluid source 14 and/or one or more sensors or sensing elements such as temperature sensors or probes. The information supplied to or gathered by the controller can be used to adjust, for example, conductive fluid delivery, power levels, and/or energization times. For example, a temperature sensor coupled to the controller can be located in the distal section 42 (FIG. 1) of the electrosurgical instrument 12. The temperature sensor can be a thermocouple element that measures the temperature of the tip 44 rather than the temperature of the conductive fluid or the temperature of the tissue being ablated. Alternatively, the temperature sensor can be a thermocouple element that measures the temperature of the conductive fluid or a thermocouple element that measures the temperature of the tissue being ablated. When the ablation site is being irrigated with a conductive fluid, the temperature of the tissue may differ to some degree from the temperature of the conductive fluid or the temperature of the tip 44.


Heat, 1.0 kcal/g, is required to raise the temperature of water, present at the ablation site, by 1° C. However, due to the unique chemical structure of the water molecule, additional heat is required for water to change phase from the liquid phase to the gaseous phase. If the temperature at the ablation site exceeds 100° C., water will change phase, boil and may result in an audible “steam pop” within the tissue. This pop may damage and even rupture the tissue. Therefore, it is desirable to prevent the ablation site from getting to hot. In addition, to form a permanent ablation lesion the temperature of the tissue at the ablation site must be elevated to approximately 50° C. or greater. For these reasons, it is desirable to use one or more temperature-sensing elements such as, for example, thermocouples, thermisters, temperature-sensing liquid crystals, temperature-sensing chemicals, thermal cameras, and/or infrared (IR) fiber optics, to monitor the temperature of the ablation site during the ablation procedure.


With the above in mind, FIGS. 9A-9C depict a portion of an alternative embodiment electrosurgical device 140, and in particular a distal section 142 thereof. The electrosurgical instrument 140 is highly similar to previous embodiments, and includes a shaft 144 terminating at an electrically conductive tip 146 having passages 148 formed therein that are fluidly connected to an internal lumen 150. Further, the electrosurgical instrument 140 includes a temperature probe 160 for monitoring tissue temperature of the tissue being ablated. The temperature probe 160 is placed at the tip 146. A ring of insulation material 162 may be used to electrically and thermally isolate the temperature probe 160 from the electrically conductive tip 146. The preferred central placement of the temperature probe 160 at the tip 146 allows the temperature probe 160 to directly contact a tissue surface in a number of orientations. The preferred insulating material 162 helps to prevent the thermal mass of the tip 146 and the RF energy from interfering with temperature information otherwise provided by the probe 160.


An alternative embodiment for monitoring temperature includes an IR optical fiber system. As shown in FIGS. 10A-10D, an alternative embodiment electrosurgical instrument 190 may include an optical fiber 192 for monitoring temperature based on IR. The optical fiber 192 can be positioned adjacent a tip 194 otherwise defined by the instrument 190 (FIGS. 10A and 10B) or within the tip 194 itself (FIGS. 10C and 10D).


The above-described temperature-sensing elements 160, 192 can be used to adjust, for example, conductive fluid delivery, power levels, and/or ablation times. Temperature-sensing elements can be coupled to a visual and/or audible signal used to alert a surgeon to a variety of thermal conditions. For example, a beeping tone or flashing light that increases in frequency as temperature of the tissue, the conductive fluid and/or electrosurgical instrument is increased and/or as temperature exceeds a predetermined amount can be used.


Along these same lines, the above-mentioned controller can incorporate one or more switches to facilitate regulation of the various components of the electrosurgical system 10 (FIG. 1) by the surgeon. One example of such a switch is a foot pedal. The switch can also be, for example, a hand switch as described above, or a voice-activated switch comprising voice-recognition technologies. The switch can be incorporated in or on one of the surgeon's instruments, such as surgical site retractor, e.g., a sternal or rib retractor, or the electrosurgical instrument 12 (FIG. 1), or any other location easily and quickly accessed by the surgeon. The controller can also include a display or other means of indicating the status of various components to the surgeon, such as a numerical display, gauges, a monitor display or audio feedback.


Finally, a visual and/or audible signal used to alert a surgeon to the completion or resumption of ablation, sensing, monitoring, and/or delivery of conductive fluid can be incorporated into the controller. For example, a beeping tone or flashing light that increases in frequency as the ablation or electrocautery period ends or begins can be provided.


In yet another alternative embodiment, the fluid source 14 can be slaved to the electrosurgical instrument 12, the power source 16 and/or one or more sensors (as previously described). For example, the fluid source 14 can be designed to automatically stop or start the delivery of conductive fluid during the delivery of RF energy. Conversely, the delivery of RF energy may be slaved to the delivery of conductive fluid. That is the delivery of RF energy to the tip 44 would be coupled to the delivery of conductive fluid to the tip 44. If the flow of conductive fluid to the tip 44 were stopped, the RF energy delivered to the tip 44 would also automatically stop. For example, a switch responsive to the delivery of conductive fluid to the tip 44 for controlling RF energy delivery to the tip 44 can be incorporated into the electrosurgical instrument 12. The switch can be located, for example, within the shaft 22 or the handle 20 of electrosurgical instrument 12.


With the above in mind, FIG. 11 illustrates a portion of an alternative embodiment electrosurgical instrument 200 including a shaft 202 extending from a handle (not shown). The shaft 202 includes an electrically conductive tip 204 and a malleable, non-conductive tube 206 rigidly connecting the tip 204 to the handle. An electrically conducting switch piston 208 is located within the non-conductive tube 206. The conducting switch piston 208 is electrically coupled to the power source 16 (FIG. 1). The conducting switch piston 208 is movably held in a non-contacting position relative to the tip 204 by a spring or other elastic means (not shown). As conductive fluid is delivered, a pressure develops behind an orifice 210 of the conducting switch piston 208. The size and shape of the orifice 210 is selected based on expected fluid delivery rates and pressures. When the necessary pressure or force to over come the spring retaining pressure or force is reached, the conducting switch 208 travels distally towards the tip 204, thereby making an electrical contact with the tip 204. Other means can be used to slave the delivery of power to the tip 204 of the electrosurgical instrument 200 to the delivery of conductive fluid to the tip 204 of the electrosurgical instrument 200. For example, the controller can incorporate one or more switches to facilitate the regulation of RF energy based on the delivery of conductive fluid.


In yet another embodiment, and with general reference to FIG. 1, the electrosurgical instrument 12, the fluid source 14 and/or the power source 16 can be slaved to a robotic system or a robotic system may be slaved to the electrosurgical instrument 12, the fluid source 14 and/or the power source 16.


The electrosurgical system, and in particular the electrosurgical instrument, of the present invention provides a marked improvement over previous designs. The handle and shaft are configured to be indifferent to rotational orientation when initially presented to a surgeon. Subsequently, the surgeon can conveniently shape or bend the shaft so as to provide a shape most conducive to forming the lesion pattern required by the particular surgical procedure. In this regard, the shaft independently maintains the selected shape throughout the particular electrosurgical procedure. Subsequently, the shaft can be re-shaped back to a straight configuration, or to any other desired curvature.


Although the invention has been described above in connection with particular embodiments and examples, it will be appreciated by those skilled in the art that the invention is not necessarily so limited, and that numerous other embodiments, examples, uses, modifications and departures from the embodiments, examples and uses are intended to be encompassed by the claims attached hereto. The entire disclosure of each patent and publication cited herein is incorporated by reference, as if each such patent or publication were individually incorporated by reference herein.

Claims
  • 1. A medical device for use in a medical procedure comprising: a manually graspable handle;an elongated shaft projecting from the handle, the shaft being sized and shaped to be positioned through a small incision in the chest of a patient and defining a proximal section comprising a rigid, elongated metal tube and a distal section comprising metal and a rounded distal tip portion adapted to be slid relative to tissue, the shaft including a joint comprising a pin that moveably couples the distal section to the proximal section thereby allowing the distal section to pivot relative to the proximal section;a non-conductive material surrounding at least a portion of the elongated shaft;a remote actuator proximal the distal section for selectively controlling the actuation of the joint;a power source comprising a battery;a light located on the distal section and electrically coupled to the power source; anda switch located on the medical device for activating the delivery of electrical power from the power source, wherein the light is visible when power is being delivered.
  • 2. The medical device of claim 1, wherein the distal section includes a passage.
  • 3. The medical device of claim 1, wherein the distal section includes an opening.
  • 4. The medical device of claim 1, wherein the distal section includes a hole.
  • 5. The medical device of claim 1, wherein the distal section includes a slot.
  • 6. The medical device of claim 1, wherein the actuator comprises a knob.
  • 7. The medical device of claim 1, wherein the actuator comprises a button.
  • 8. The medical device of claim 1, wherein the actuator comprises a lever.
  • 9. The medical device of claim 1, wherein the actuator comprises a slide.
  • 10. The medical device of claim 1, wherein at least a portion of the distal section of the elongated shaft defines a uniform radius of curvature.
  • 11. The medical device of claim 1, wherein the handle is rigidly coupled to the shaft such that the shaft is readily manipulated via movement of the handle.
  • 12. The medical device of claim 1, further comprising a sensor located at the distal section of the elongated shaft.
  • 13. The medical device of claim 1, wherein the actuator is located at the handle.
  • 14. The medical device of claim 1, wherein the proximal section includes an internal lumen.
  • 15. The medical device of claim 1, wherein at least a portion of the shaft is malleable.
  • 16. The medical device of claim 1, wherein the medical procedure is an ablation procedure.
  • 17. A medical device for use in a medical procedure comprising: a manually graspable, non-conductive handle;an elongated shaft projecting from the handle, the shaft being sized and shaped to be positioned through a small incision in the chest of a patient and defining a proximal section comprising a rigid, elongated metal tube and a distal section comprising metal and a rounded tip portion adapted to be slid relative to tissue, the rounded tip portion being free of any electrode movable relative to the rounded tip portion, the shaft including a joint comprising a pin that moveably couples the distal section to the proximal section thereby allowing the distal section to pivot relative to the proximal section;a non-conductive material surrounding at least a portion of the elongated shaft;a remote actuator located at the handle for selectively controlling the actuation of the joint;a power source comprising a battery;a light located on the medical device and electrically coupled to the power source; andan activator located at the handle for activating the delivery of power from the power source, wherein the light is visible when power is being delivered.
US Referenced Citations (641)
Number Name Date Kind
1127948 Wappler Feb 1915 A
1735271 Groff Nov 1929 A
2004559 Wappler et al. Jun 1935 A
3470875 Johnson et al. Oct 1969 A
3630207 Kahn et al. Dec 1971 A
3736936 Basiulis et al. Jun 1973 A
3807403 Stumpf et al. Apr 1974 A
3823575 Parel Jul 1974 A
3823718 Tromovitch Jul 1974 A
3827436 Stumpf et al. Aug 1974 A
3830239 Stumpf Aug 1974 A
3859986 Okada et al. Jan 1975 A
3862627 Hans, Sr. Jan 1975 A
3886945 Stumpf et al. Jun 1975 A
3901242 Storz Aug 1975 A
3907339 Stumpf et al. Sep 1975 A
3910277 Zimmer Oct 1975 A
3913581 Ritson et al. Oct 1975 A
3924628 Droegemueller et al. Dec 1975 A
4018227 Wallach Apr 1977 A
4022215 Benson May 1977 A
4043342 Morrison, Jr. Aug 1977 A
4061135 Widran et al. Dec 1977 A
4063560 Thomas et al. Dec 1977 A
4072152 Linehan Feb 1978 A
4082096 Benson Apr 1978 A
4207897 Lloyd et al. Jun 1980 A
4248224 Jones Feb 1981 A
4275734 Mitchiner Jun 1981 A
4278090 van Gerven Jul 1981 A
4312337 Donohue et al. Jan 1982 A
4326529 Doss et al. Apr 1982 A
4353371 Cosman Oct 1982 A
4377168 Rzasa et al. Mar 1983 A
4492231 Auth Jan 1985 A
4519389 Gudkin et al. May 1985 A
4590934 Malis et al. May 1986 A
4598698 Siegmund Jul 1986 A
4601290 Effron et al. Jul 1986 A
4664110 Schanzlin May 1987 A
4706667 Roos Nov 1987 A
4732149 Sutter Mar 1988 A
4736749 Lundback Apr 1988 A
4779611 Grooters et al. Oct 1988 A
4802475 Weshahy Feb 1989 A
4815470 Curtis et al. Mar 1989 A
4872346 Kelly-Fry et al. Oct 1989 A
4916922 Mullens Apr 1990 A
4917095 Fry et al. Apr 1990 A
4920982 Goldstein May 1990 A
4936281 Stasz Jun 1990 A
4940064 Desai Jul 1990 A
4946460 Merry et al. Aug 1990 A
5009661 Michelson Apr 1991 A
5013312 Parins et al. May 1991 A
5029574 Shimamura et al. Jul 1991 A
5033477 Chin et al. Jul 1991 A
5044165 Linner et al. Sep 1991 A
5044947 Sachdeva et al. Sep 1991 A
5071428 Chin et al. Dec 1991 A
5078713 Varney Jan 1992 A
5080102 Dory Jan 1992 A
5080660 Buelna Jan 1992 A
5083565 Parins Jan 1992 A
5085657 Ben-Simhon Feb 1992 A
5087243 Avitall Feb 1992 A
5100388 Behl et al. Mar 1992 A
5108390 Potocky et al. Apr 1992 A
5116332 Lottick May 1992 A
5125928 Parins et al. Jun 1992 A
5147355 Friedman et al. Sep 1992 A
5151102 Kamiyama et al. Sep 1992 A
5156151 Imran Oct 1992 A
5156613 Sawyer Oct 1992 A
5167659 Ohtomo et al. Dec 1992 A
5178133 Pena Jan 1993 A
5190541 Abele et al. Mar 1993 A
5207674 Hamilton May 1993 A
5207691 Nardella May 1993 A
5217460 Knoepfler Jun 1993 A
5217860 Fahy et al. Jun 1993 A
5222501 Ideker et al. Jun 1993 A
5224943 Goddard Jul 1993 A
5228923 Hed Jul 1993 A
5231995 Desai Aug 1993 A
5232516 Hed Aug 1993 A
5242441 Avitall Sep 1993 A
5242458 Bendel et al. Sep 1993 A
5250047 Rydell Oct 1993 A
5250075 Badie Oct 1993 A
5254116 Baust et al. Oct 1993 A
5254130 Poncet et al. Oct 1993 A
5263493 Avitall Nov 1993 A
5269291 Carter Dec 1993 A
5269326 Verrier Dec 1993 A
5269780 Roos Dec 1993 A
5275595 Dobak, III Jan 1994 A
5277201 Stern Jan 1994 A
5281213 Milder et al. Jan 1994 A
5281215 Milder Jan 1994 A
5281216 Klicek Jan 1994 A
5293869 Edwards et al. Mar 1994 A
5295484 Marcus et al. Mar 1994 A
5300087 Knoepfler Apr 1994 A
5306234 Johnson Apr 1994 A
5309896 Moll et al. May 1994 A
5314466 Stern May 1994 A
5316000 Chapelon et al. May 1994 A
5317878 Bradshaw et al. Jun 1994 A
5318525 West et al. Jun 1994 A
5318589 Lichtman Jun 1994 A
5322520 Milder Jun 1994 A
5323781 Ideker et al. Jun 1994 A
5324255 Passafaro et al. Jun 1994 A
5324284 Imran Jun 1994 A
5324286 Fowle Jun 1994 A
5327905 Avitall Jul 1994 A
5334181 Rubinsky et al. Aug 1994 A
5334193 Nardella Aug 1994 A
5336252 Cohen Aug 1994 A
5348554 Imran et al. Sep 1994 A
5353783 Nakao et al. Oct 1994 A
5354258 Dory Oct 1994 A
5354297 Avitall Oct 1994 A
5357956 Nardella Oct 1994 A
5361752 Moll et al. Nov 1994 A
5364394 Mehl Nov 1994 A
5383874 Jackson et al. Jan 1995 A
5385148 Lesh et al. Jan 1995 A
5395312 Desai Mar 1995 A
5395363 Billings et al. Mar 1995 A
5396887 Imran Mar 1995 A
5397304 Truckai Mar 1995 A
5397339 Desai Mar 1995 A
5400770 Nakao et al. Mar 1995 A
5400783 Pomeranz et al. Mar 1995 A
5401272 Perkins Mar 1995 A
5403309 Coleman et al. Apr 1995 A
5403311 Abele et al. Apr 1995 A
5403312 Yates et al. Apr 1995 A
5405376 Mulier et al. Apr 1995 A
5409483 Campbell et al. Apr 1995 A
5423807 Milder Jun 1995 A
5423811 Imran et al. Jun 1995 A
5427119 Swartz et al. Jun 1995 A
5429131 Scheinman et al. Jul 1995 A
5429636 Shikhman et al. Jul 1995 A
5431649 Mulier et al. Jul 1995 A
5433708 Nichols et al. Jul 1995 A
5435308 Gallup et al. Jul 1995 A
5437651 Todd et al. Aug 1995 A
5438302 Goble Aug 1995 A
5441483 Avitall Aug 1995 A
5441499 Fritzsch Aug 1995 A
5443463 Stern et al. Aug 1995 A
5443470 Stern et al. Aug 1995 A
5445638 Rydell et al. Aug 1995 A
5449355 Rhum et al. Sep 1995 A
5450843 Moll et al. Sep 1995 A
5451223 Ben-Simhon Sep 1995 A
5452582 Longsworth Sep 1995 A
5452733 Sterman et al. Sep 1995 A
5454370 Avitall Oct 1995 A
5458596 Lax et al. Oct 1995 A
5458598 Feinberg et al. Oct 1995 A
5462545 Wang et al. Oct 1995 A
5465716 Avitall Nov 1995 A
5465717 Imran et al. Nov 1995 A
5469853 Law et al. Nov 1995 A
5472441 Edwards et al. Dec 1995 A
5472876 Fahy Dec 1995 A
5478309 Sweezer et al. Dec 1995 A
5478330 Imran et al. Dec 1995 A
5480409 Riza Jan 1996 A
5486193 Bourne et al. Jan 1996 A
5487385 Avitall Jan 1996 A
5487757 Truckai et al. Jan 1996 A
5496312 Klicek Mar 1996 A
5497774 Swartz et al. Mar 1996 A
5498248 Milder Mar 1996 A
5500011 Desai Mar 1996 A
5500012 Brucker et al. Mar 1996 A
5505730 Edwards Apr 1996 A
5516505 McDow May 1996 A
5520682 Baust et al. May 1996 A
5522788 Kuzmak Jun 1996 A
5522870 Ben-Zion Jun 1996 A
5531744 Nardella et al. Jul 1996 A
5536267 Edwards et al. Jul 1996 A
5545195 Lennox et al. Aug 1996 A
5545200 West et al. Aug 1996 A
5549636 Li Aug 1996 A
5549661 Kordis et al. Aug 1996 A
5555883 Avitall Sep 1996 A
5558671 Yates Sep 1996 A
5560362 Sliwa, Jr. et al. Oct 1996 A
5562699 Heimberger et al. Oct 1996 A
5562700 Huitema et al. Oct 1996 A
5562720 Stern et al. Oct 1996 A
5562721 Marchlinski et al. Oct 1996 A
5564440 Swartz et al. Oct 1996 A
5569241 Edwards Oct 1996 A
5569242 Lax et al. Oct 1996 A
5571088 Lennox et al. Nov 1996 A
5571119 Atala Nov 1996 A
5571215 Sterman et al. Nov 1996 A
5573532 Chang et al. Nov 1996 A
5575766 Swartz et al. Nov 1996 A
5575788 Baker et al. Nov 1996 A
5575805 Li Nov 1996 A
5575810 Swanson et al. Nov 1996 A
5578007 Imran Nov 1996 A
5582609 Swanson et al. Dec 1996 A
5584872 LaFontaine et al. Dec 1996 A
5587723 Otake et al. Dec 1996 A
5588432 Crowley Dec 1996 A
5590657 Cain et al. Jan 1997 A
5591192 Privitera et al. Jan 1997 A
5595183 Swanson et al. Jan 1997 A
5599348 Gentelia et al. Feb 1997 A
5599350 Schulze et al. Feb 1997 A
5607462 Imran Mar 1997 A
5609151 Mulier et al. Mar 1997 A
5611813 Lichtman Mar 1997 A
5617854 Munsif Apr 1997 A
5620459 Lichtman Apr 1997 A
5630837 Crowley May 1997 A
5632717 Yoon May 1997 A
5637090 McGee et al. Jun 1997 A
5642736 Avitall Jul 1997 A
5643197 Brucker et al. Jul 1997 A
5647871 Levine et al. Jul 1997 A
5649957 Levin Jul 1997 A
5655219 Jusa et al. Aug 1997 A
5656029 Imran et al. Aug 1997 A
5657755 Desai Aug 1997 A
5658278 Imran et al. Aug 1997 A
5671747 Connor Sep 1997 A
5672174 Gough et al. Sep 1997 A
5673695 McGee et al. Oct 1997 A
5674220 Fox et al. Oct 1997 A
5676662 Fleischhacker et al. Oct 1997 A
5676692 Sanghvi et al. Oct 1997 A
5676693 LaFontaine Oct 1997 A
5678550 Bassen et al. Oct 1997 A
5680860 Imran Oct 1997 A
5681278 Igo et al. Oct 1997 A
5681308 Edwards et al. Oct 1997 A
5683384 Gough et al. Nov 1997 A
5687723 Avitall Nov 1997 A
5687737 Branham et al. Nov 1997 A
5688267 Panescu et al. Nov 1997 A
5688270 Yates et al. Nov 1997 A
5690611 Swartz et al. Nov 1997 A
5693051 Schulze et al. Dec 1997 A
5697536 Eggers et al. Dec 1997 A
5697882 Eggers et al. Dec 1997 A
5697925 Taylor Dec 1997 A
5697927 Imran et al. Dec 1997 A
5697928 Walcott et al. Dec 1997 A
5702359 Hofmann et al. Dec 1997 A
5702390 Austin et al. Dec 1997 A
5702438 Avitall Dec 1997 A
5709680 Yates et al. Jan 1998 A
5713942 Stern et al. Feb 1998 A
5716389 Walinsky et al. Feb 1998 A
5718241 Ben-Haim et al. Feb 1998 A
5718701 Shai et al. Feb 1998 A
5718703 Chin Feb 1998 A
5720775 Larnard Feb 1998 A
5722402 Swanson et al. Mar 1998 A
5722403 McGee et al. Mar 1998 A
5725512 Swartz et al. Mar 1998 A
5725524 Mulier et al. Mar 1998 A
5728143 Gough et al. Mar 1998 A
5730074 Peter Mar 1998 A
5730127 Avitall Mar 1998 A
5730704 Avitall Mar 1998 A
5733280 Avitall Mar 1998 A
5735280 Sherman et al. Apr 1998 A
5735290 Sterman et al. Apr 1998 A
5735847 Gough et al. Apr 1998 A
5735849 Baden et al. Apr 1998 A
5738628 Sierocuk et al. Apr 1998 A
5740808 Panescu et al. Apr 1998 A
5755664 Rubenstein May 1998 A
5755717 Yates et al. May 1998 A
5755760 Maguire et al. May 1998 A
5759158 Swanson Jun 1998 A
5769846 Edwards et al. Jun 1998 A
5776130 Buysse et al. Jul 1998 A
5782826 Swanson Jul 1998 A
5782827 Gough et al. Jul 1998 A
5782828 Chen et al. Jul 1998 A
5785706 Bednarek Jul 1998 A
H1745 Paraschac Aug 1998 H
5788636 Curley Aug 1998 A
5792140 Tu et al. Aug 1998 A
5796188 Bays Aug 1998 A
5797906 Rhum et al. Aug 1998 A
5797959 Castro et al. Aug 1998 A
5797960 Stevens et al. Aug 1998 A
5800428 Nelson et al. Sep 1998 A
5800482 Pomeranz et al. Sep 1998 A
5800484 Gough et al. Sep 1998 A
5807393 Williamson, IV et al. Sep 1998 A
5807395 Mulier et al. Sep 1998 A
5810802 Panescu et al. Sep 1998 A
5810804 Gough et al. Sep 1998 A
5810805 Sutcu et al. Sep 1998 A
5810811 Yates et al. Sep 1998 A
5814028 Swartz et al. Sep 1998 A
5817091 Nardella et al. Oct 1998 A
5823955 Kuck et al. Oct 1998 A
5823956 Roth et al. Oct 1998 A
5827216 Igo et al. Oct 1998 A
5827271 Buysse et al. Oct 1998 A
5829447 Stevens et al. Nov 1998 A
5836947 Fleischman et al. Nov 1998 A
5840030 Ferek-Petric et al. Nov 1998 A
5842984 Avitall Dec 1998 A
5843075 Taylor Dec 1998 A
5843122 Riza Dec 1998 A
5844349 Oakley et al. Dec 1998 A
5846187 Wells et al. Dec 1998 A
5846191 Wells et al. Dec 1998 A
5846238 Jackson et al. Dec 1998 A
5849011 Jones et al. Dec 1998 A
5849020 Long et al. Dec 1998 A
5849028 Chen Dec 1998 A
5853411 Whayne et al. Dec 1998 A
5855590 Malecki et al. Jan 1999 A
5855614 Stevens et al. Jan 1999 A
5860975 Goble et al. Jan 1999 A
5863290 Gough et al. Jan 1999 A
5863291 Schaer Jan 1999 A
5868737 Taylor et al. Feb 1999 A
5871483 Jackson et al. Feb 1999 A
5871523 Fleischman et al. Feb 1999 A
5871525 Edwards et al. Feb 1999 A
5873845 Cline et al. Feb 1999 A
5873896 Ideker Feb 1999 A
5876398 Mulier et al. Mar 1999 A
5876399 Chia et al. Mar 1999 A
5876400 Songer Mar 1999 A
5876401 Schulze et al. Mar 1999 A
5879295 Li et al. Mar 1999 A
5879296 Ockuly et al. Mar 1999 A
5881732 Sung et al. Mar 1999 A
5882346 Pomeranz et al. Mar 1999 A
5883690 Meyers et al. Mar 1999 A
5883703 Knirck et al. Mar 1999 A
5885278 Fleischman Mar 1999 A
5891135 Jackson et al. Apr 1999 A
5891136 McGee et al. Apr 1999 A
5891138 Tu et al. Apr 1999 A
5893848 Negus et al. Apr 1999 A
5893863 Yoon Apr 1999 A
5895417 Pomeranz et al. Apr 1999 A
5897553 Mulier et al. Apr 1999 A
5897554 Chia et al. Apr 1999 A
5899898 Arless et al. May 1999 A
5899899 Arless et al. May 1999 A
5902289 Swartz et al. May 1999 A
5904711 Flom et al. May 1999 A
5906580 Kline-Schoder et al. May 1999 A
5906587 Zimmon May 1999 A
5906606 Chee et al. May 1999 A
5908029 Knudson et al. Jun 1999 A
5910129 Koblish et al. Jun 1999 A
5913855 Gough et al. Jun 1999 A
5916213 Haissaguerre et al. Jun 1999 A
5916214 Cosio et al. Jun 1999 A
5921924 Avitall Jul 1999 A
5921982 Lesh et al. Jul 1999 A
5925038 Panescu et al. Jul 1999 A
5925042 Gough et al. Jul 1999 A
5925424 Goswami et al. Jul 1999 A
5927284 Borst et al. Jul 1999 A
5928138 Knight et al. Jul 1999 A
5928191 Houser et al. Jul 1999 A
5928229 Gough et al. Jul 1999 A
5931810 Grabek Aug 1999 A
5931836 Hatta et al. Aug 1999 A
5931848 Saadat Aug 1999 A
5935126 Riza Aug 1999 A
5938660 Swartz et al. Aug 1999 A
5941251 Panescu et al. Aug 1999 A
5941845 Tu et al. Aug 1999 A
5944718 Austin et al. Aug 1999 A
5947938 Swartz et al. Sep 1999 A
5951546 Lorentzen Sep 1999 A
5951547 Gough et al. Sep 1999 A
5951552 Long et al. Sep 1999 A
5954661 Greenspon et al. Sep 1999 A
5954665 Ben-Haim Sep 1999 A
5961514 Long et al. Oct 1999 A
5964755 Edwards Oct 1999 A
5967976 Larsen et al. Oct 1999 A
5971980 Sherman Oct 1999 A
5971983 Lesh Oct 1999 A
5972013 Schmidt Oct 1999 A
5972026 Laufer et al. Oct 1999 A
5980516 Mulier et al. Nov 1999 A
5980517 Gough Nov 1999 A
5984281 Hacker et al. Nov 1999 A
5993447 Blewett et al. Nov 1999 A
5997533 Kuhns Dec 1999 A
6007499 Martin et al. Dec 1999 A
6010516 Hulka Jan 2000 A
6010531 Donlon et al. Jan 2000 A
6012457 Lesh Jan 2000 A
6013074 Taylor Jan 2000 A
6016809 Mulier et al. Jan 2000 A
6016811 Knopp et al. Jan 2000 A
6017358 Yoon et al. Jan 2000 A
6023638 Swanson Feb 2000 A
6024740 Lesh et al. Feb 2000 A
6024741 Williamson et al. Feb 2000 A
6030403 Long et al. Feb 2000 A
6033402 Tu et al. Mar 2000 A
6036670 Wijeratne et al. Mar 2000 A
6039731 Taylor et al. Mar 2000 A
6039733 Buysse et al. Mar 2000 A
6039748 Savage et al. Mar 2000 A
6042556 Beach et al. Mar 2000 A
6047218 Whayne et al. Apr 2000 A
6048329 Thompson et al. Apr 2000 A
6050996 Schmaltz et al. Apr 2000 A
6053172 Hovda et al. Apr 2000 A
6056745 Panescu May 2000 A
6063081 Mulier et al. May 2000 A
6064902 Haissaguerre et al. May 2000 A
6068653 LaFontaine May 2000 A
6071279 Whayne et al. Jun 2000 A
6071281 Burnside et al. Jun 2000 A
6083150 Aznoian et al. Jul 2000 A
6083222 Klein et al. Jul 2000 A
6088894 Oakley et al. Jul 2000 A
6096037 Mulier et al. Aug 2000 A
6110098 Renirie et al. Aug 2000 A
6113592 Taylor Sep 2000 A
6113595 Muntermann Sep 2000 A
6113598 Baker Sep 2000 A
6117101 Diederich et al. Sep 2000 A
6117150 Pingleton et al. Sep 2000 A
6120496 Whayne et al. Sep 2000 A
6123702 Swanson et al. Sep 2000 A
6123703 Tu et al. Sep 2000 A
6126658 Baker Oct 2000 A
6129662 Li et al. Oct 2000 A
6139545 Utley et al. Oct 2000 A
6142993 Whayne et al. Nov 2000 A
6142994 Swanson et al. Nov 2000 A
6152920 Thompson et al. Nov 2000 A
6156009 Grabek Dec 2000 A
6156033 Tu et al. Dec 2000 A
6161543 Cox et al. Dec 2000 A
6162195 Igo et al. Dec 2000 A
6162220 Nezhat Dec 2000 A
6165174 Jacobs et al. Dec 2000 A
6176856 Jandak et al. Jan 2001 B1
6185356 Parker et al. Feb 2001 B1
6193713 Geistert et al. Feb 2001 B1
6203557 Chin Mar 2001 B1
6206004 Schmidt et al. Mar 2001 B1
6206823 Kolata et al. Mar 2001 B1
6217528 Koblish et al. Apr 2001 B1
6217576 Tu et al. Apr 2001 B1
6224592 Eggers et al. May 2001 B1
6231518 Grabek et al. May 2001 B1
6235024 Tu May 2001 B1
6237605 Vaska et al. May 2001 B1
6238347 Nix et al. May 2001 B1
6238393 Mulier et al. May 2001 B1
6245061 Panescu et al. Jun 2001 B1
6245064 Lesh et al. Jun 2001 B1
6245065 Panescu et al. Jun 2001 B1
6251092 Qin et al. Jun 2001 B1
6251128 Knopp et al. Jun 2001 B1
6264087 Whitman Jul 2001 B1
6264670 Chin Jul 2001 B1
6267761 Ryan Jul 2001 B1
6270471 Hechel et al. Aug 2001 B1
6273887 Yamauchi et al. Aug 2001 B1
6277117 Tetzlaff et al. Aug 2001 B1
6292678 Hall et al. Sep 2001 B1
6293943 Panescu et al. Sep 2001 B1
6296619 Brisken et al. Oct 2001 B1
6296639 Truckai et al. Oct 2001 B1
6296640 Wampler et al. Oct 2001 B1
6302880 Schaer Oct 2001 B1
6304712 Davis Oct 2001 B1
6308091 Avitall Oct 2001 B1
6311692 Vaska et al. Nov 2001 B1
6312383 Lizzi et al. Nov 2001 B1
6314962 Vaska et al. Nov 2001 B1
6314963 Vaska et al. Nov 2001 B1
6325797 Stewart et al. Dec 2001 B1
6328688 Borst et al. Dec 2001 B1
6328736 Mulier Dec 2001 B1
6332089 Acker et al. Dec 2001 B1
6332881 Carner et al. Dec 2001 B1
6334860 Dorn Jan 2002 B1
6356790 Maguire et al. Mar 2002 B1
6358248 Mulier et al. Mar 2002 B1
6358249 Chen et al. Mar 2002 B1
6361531 Hissong Mar 2002 B1
6363279 Ben-Haim et al. Mar 2002 B1
6364876 Erb et al. Apr 2002 B1
6368275 Sliwa et al. Apr 2002 B1
6371955 Fuimaono et al. Apr 2002 B1
6383151 Diederich et al. May 2002 B1
6385472 Hall et al. May 2002 B1
6391024 Sun et al. May 2002 B1
6395038 Schroeppel May 2002 B1
6398792 O'Connor Jun 2002 B1
6405078 Moaddeb et al. Jun 2002 B1
6409722 Hoey et al. Jun 2002 B1
6413254 Hissong et al. Jul 2002 B1
6419648 Vitek et al. Jul 2002 B1
6423051 Kaplan et al. Jul 2002 B1
6425867 Vaezy et al. Jul 2002 B1
6428180 Karram et al. Aug 2002 B1
6430426 Avitall Aug 2002 B2
6440130 Mulier et al. Aug 2002 B1
6443952 Mulier et al. Sep 2002 B1
6443970 Schulze et al. Sep 2002 B1
6447507 Bednarek et al. Sep 2002 B1
6451014 Wakikaido et al. Sep 2002 B1
6461314 Pant et al. Oct 2002 B1
6461956 Hsuan et al. Oct 2002 B1
6464700 Koblish et al. Oct 2002 B1
6471697 Lesh Oct 2002 B1
6471698 Edwards et al. Oct 2002 B1
6474340 Vaska et al. Nov 2002 B1
6475216 Mulier et al. Nov 2002 B2
6477396 Mest et al. Nov 2002 B1
6484727 Vaska et al. Nov 2002 B1
6488678 Sherman Dec 2002 B2
6488680 Francischelli et al. Dec 2002 B1
6502575 Jacobs et al. Jan 2003 B1
6504985 Parker et al. Jan 2003 B2
6506189 Rittman, III et al. Jan 2003 B1
6506200 Chin Jan 2003 B1
6514250 Jahns et al. Feb 2003 B1
6517536 Hooven et al. Feb 2003 B2
6520927 Unsworth Feb 2003 B1
6522930 Schaer et al. Feb 2003 B1
6527767 Wang et al. Mar 2003 B2
6537248 Mulier et al. Mar 2003 B2
6537272 Christopherson et al. Mar 2003 B2
6540740 Lehmann et al. Apr 2003 B2
6546935 Hooven Apr 2003 B2
6554768 Leonard Apr 2003 B1
6558382 Jahns et al. May 2003 B2
6575969 Rittman, III et al. Jun 2003 B1
6584360 Francischelli et al. Jun 2003 B2
6585732 Mulier Jul 2003 B2
6591049 Williams et al. Jul 2003 B2
6605084 Acker et al. Aug 2003 B2
6610055 Swanson et al. Aug 2003 B1
6610060 Mulier Aug 2003 B2
6613048 Mulier Sep 2003 B2
6632222 Edwards et al. Oct 2003 B1
6645199 Jenkins et al. Nov 2003 B1
6648883 Francischelli et al. Nov 2003 B2
6651672 Roth Nov 2003 B2
6656175 Francischelli et al. Dec 2003 B2
6663626 Truckai et al. Dec 2003 B2
6663627 Francischelli et al. Dec 2003 B2
6679882 Kornerup Jan 2004 B1
6692450 Coleman Feb 2004 B1
6692491 Phan Feb 2004 B1
6699240 Francischelli Mar 2004 B2
6702811 Stewart et al. Mar 2004 B2
6706038 Francischelli et al. Mar 2004 B2
6706039 Mulier et al. Mar 2004 B2
6716211 Mulier et al. Apr 2004 B2
6736810 Hoey et al. May 2004 B2
6755827 Mulier et al. Jun 2004 B2
6764487 Mulier et al. Jul 2004 B2
6773433 Stewart et al. Aug 2004 B2
6776780 Mulier et al. Aug 2004 B2
6802840 Chin et al. Oct 2004 B2
6807968 Francischelli et al. Oct 2004 B2
6827715 Francischelli et al. Dec 2004 B2
6849073 Hoey et al. Feb 2005 B2
6858028 Mulier et al. Feb 2005 B2
6887238 Jahns et al. May 2005 B2
6899711 Stewart et al. May 2005 B2
6911019 Mulier et al. Jun 2005 B2
6916318 Francischelli et al. Jul 2005 B2
6936046 Hissong Aug 2005 B2
6949097 Stewart et al. Sep 2005 B2
6949098 Mulier Sep 2005 B2
6960205 Jahns Nov 2005 B2
6962589 Mulier Nov 2005 B2
7056329 Kerr Jun 2006 B2
7507235 Keogh et al. Mar 2009 B2
20010039419 Francischelli et al. Nov 2001 A1
20020009275 Williams et al. Jan 2002 A1
20020087183 Boyd et al. Jul 2002 A1
20020107517 Witt et al. Aug 2002 A1
20020120263 Brown et al. Aug 2002 A1
20020138109 Keogh et al. Sep 2002 A1
20030045872 Jacobs et al. Mar 2003 A1
20030144656 Ocel et al. Jul 2003 A1
20030163128 Patil et al. Aug 2003 A1
20030191462 Jacobs et al. Oct 2003 A1
20030216724 Jahns Nov 2003 A1
20040015106 Coleman Jan 2004 A1
20040015219 Francischelli Jan 2004 A1
20040044340 Francischelli et al. Mar 2004 A1
20040049179 Francischelli et al. Mar 2004 A1
20040078069 Francischelli et al. Apr 2004 A1
20040082948 Stewart et al. Apr 2004 A1
20040087940 Jahns et al. May 2004 A1
20040092926 Hoey et al. May 2004 A1
20040138621 Jahns et al. Jul 2004 A1
20040138656 Francischelli et al. Jul 2004 A1
20040143260 Francischelli Jul 2004 A1
20040186465 Francischelli et al. Sep 2004 A1
20040204734 Wagner et al. Oct 2004 A1
20040215183 Hoey et al. Oct 2004 A1
20040220560 Briscoe Nov 2004 A1
20040236322 Mulier et al. Nov 2004 A1
20040249368 Hooven Dec 2004 A1
20040267326 Ocel Dec 2004 A1
20050010095 Stewart et al. Jan 2005 A1
20050033280 Francischelli et al. Feb 2005 A1
20050090815 Francischelli et al. Apr 2005 A1
20050143729 Francischelli et al. Jun 2005 A1
20050165392 Francischelli et al. Jul 2005 A1
20050203561 Palmer et al. Sep 2005 A1
20050203562 Palmer et al. Sep 2005 A1
20050209564 Bonner et al. Sep 2005 A1
20050267454 Hissong et al. Dec 2005 A1
20060009756 Francischelli et al. Jan 2006 A1
20060009759 Chrisitian et al. Jan 2006 A1
20070043397 Ocel Feb 2007 A1
Foreign Referenced Citations (31)
Number Date Country
43 13 903 Sep 1994 DE
0 450 608 Oct 1991 EP
0 765 639 Apr 1997 EP
1 095 627 May 2001 EP
9205828 Apr 1992 WO
9325267 Dec 1993 WO
9710764 Mar 1997 WO
9732525 Sep 1997 WO
9817187 Apr 1998 WO
9853750 Dec 1998 WO
9902096 Jan 1999 WO
9904696 Feb 1999 WO
9912487 Mar 1999 WO
9944519 Sep 1999 WO
9956486 Nov 1999 WO
9956644 Nov 1999 WO
9956648 Nov 1999 WO
9959486 Nov 1999 WO
0021449 Apr 2000 WO
0027310 May 2000 WO
0027311 May 2000 WO
0027312 May 2000 WO
0027313 May 2000 WO
0042931 Jul 2000 WO
0042932 Jul 2000 WO
0042933 Jul 2000 WO
0042934 Jul 2000 WO
0180755 Nov 2001 WO
0182812 Nov 2001 WO
0182813 Nov 2001 WO
02087454 Nov 2002 WO
Related Publications (1)
Number Date Country
20030144656 A1 Jul 2003 US